WOBURN, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (“NeuroMetrix” or the “Company”) (Nasdaq: NURO) today announced it has entered into a ...

Over the past three years, NeuroMetrix's EPS fell by 19% and over the past three years, the total loss to shareholders 82% NeuroMetrix, Inc. (NASDAQ:NURO) has not performed well recently and CEO Shai ...

NeuroMetrix, Inc. (NURO), a health technology company, has seen its stock tumble to a 52-week low, reaching a price level of just $2.66. This latest dip represents a significant decline for the ...

NeuroMetrix, Inc. (NASDAQ:NURO) reported a year-on-year decrease in Q3 2023 revenues during its earnings call, attributing the decline to changes in Medicare Advantage patient screening rules and a ...

Just because a business does not make any money, does not mean that the stock will go down. Indeed, NeuroMetrix (NASDAQ:NURO) stock is up 920% in the last year, providing strong gains for shareholders ...